Analysis of Circulating Angiopoietin-like Protein 3 and Genetic Variants in Lipid Metabolism and Liver Health: the DiOGenes Study

Overview

Journal Genes Nutr

Publisher Biomed Central

Date 2018 Apr 6

PMID 29619113

Citations 8

Authors

Anne Lundby Hess

Jerome Carayol

Trine Blaedel

Jorg Hager

Alessandro Di Cara

Arne Astrup

Wim H M Saris

Lesli Hingstrup Larsen

Armand Valsesia

Affiliations

Soon will be listed here.

Abstract

Background: Angiopoietin-like protein 3 (ANGPTL3), a liver-derived protein, plays an important role in the lipid and lipoprotein metabolism. Using data available from the DiOGenes study, we assessed the link with clinical improvements (weight, plasma lipid, and insulin levels) and changes in liver markers, alanine aminotransferase, aspartate aminotransferase (AST), adiponectin, fetuin A and B, and cytokeratin 18 (CK-18), upon low-calorie diet (LCD) intervention. We also examined the role of genetic variation in determining the level of circulating ANGPTL3 and the relation between the identified genetic markers and markers of hepatic steatosis.

Methods: DiOGenes is a multicenter, controlled dietary intervention where obese participants followed an 8-week LCD (800 kcal/day, using a meal replacement product). Plasma ANGPTL3 and liver markers were measured using the SomaLogic (Boulder, CO) platform. Protein quantitative trait locus (pQTL) analyses assessed the link between more than four million common variants and the level of circulating ANGPTL3 at baseline and changes in levels during the LCD intervention.

Results: Changes in ANGPTL3 during weight loss showed only marginal association with changes in triglycerides (nominal = 0.02) and insulin ( = 0.04); these results did not remain significant after correcting for multiple testing. However, significant association (after multiple-testing correction) were observed between changes in ANGPTL3 and AST during weight loss ( = 0.004) and between ANGPTL3 and CK-18 (baseline = 1.03 × 10, during weight loss = 1.47 × 10). Our pQTL study identified two loci significantly associated with changes in ANGPTL3. One of these loci (the -- gene cluster) also displayed significant association with changes in CK-18 levels during weight loss ( = 0.007).

Conclusion: We clarify the link between circulating levels of ANGPTL3 and specific markers of liver function. We demonstrate that changes in ANGPLT3 and CK-18 during LCD are under genetic control from -acting variants. Our results suggest an extended function of ANGPTL3 in the inflammatory state of liver steatosis and toward liver metabolic processes.

Citing Articles

Characterization and Proteomic Profiling of Hepatocyte-like Cells Derived from Human Wharton's Jelly Mesenchymal Stromal Cells: De Novo Expression of Liver-Specific Enzymes.

Lo Iacono M, Corrao S, Alberti G, Amico G, Timoneri F, Russo E Biology (Basel). 2025; 14(2).

PMID: 40001892 PMC: 11851833. DOI: 10.3390/biology14020124.

Genetic association of serum lipids and lipid-modifying targets with endometriosis: Trans-ethnic Mendelian-randomization and mediation analysis.

Zhang H, Fan Y, Li H, Feng X, Yue D PLoS One. 2024; 19(5):e0301752.

PMID: 38820493 PMC: 11142702. DOI: 10.1371/journal.pone.0301752.

Role of the angiopoietin-like protein family in the progression of NAFLD.

Su X, Xu Q, Li Z, Ren Y, Jiao Q, Wang L Heliyon. 2024; 10(7):e27739.

PMID: 38560164 PMC: 10980950. DOI: 10.1016/j.heliyon.2024.e27739.

Pan-Cancer Profiling and Digital Pathology Analysis Reveal Negative Prognostic Biomarker ZPR1 Associated with Immune Infiltration and Treatment Response in Hepatocellular Carcinoma.

He L, Xie Y, Qiu Y, Zhang Y J Hepatocell Carcinoma. 2023; 10:1309-1325.

PMID: 37581094 PMC: 10423584. DOI: 10.2147/JHC.S415224.

ANGPTL3 gene variants in subjects with familial combined hyperlipidemia.

Bea A, Franco-Marin E, Marco-Benedi V, Jarauta E, Gracia-Rubio I, Cenarro A Sci Rep. 2021; 11(1):7002.

PMID: 33772079 PMC: 7997994. DOI: 10.1038/s41598-021-86384-y.

References

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

Yilmaz Y, Ulukaya E, Atug O, Dolar E . Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance. Eur J Gastroenterol Hepatol. 2009; 21(11):1247-51. DOI: 10.1097/MEG.0b013e32832b77ae. View

Giannini E, Testa R, Savarino V . Liver enzyme alteration: a guide for clinicians. CMAJ. 2005; 172(3):367-79. PMC: 545762. DOI: 10.1503/cmaj.1040752. View

Fu Q, Tang X, Chen J, Su L, Zhang M, Wang L . Effects of Polymorphisms in APOA4-APOA5-ZNF259-BUD13 Gene Cluster on Plasma Levels of Triglycerides and Risk of Coronary Heart Disease in a Chinese Han Population. PLoS One. 2015; 10(9):e0138652. PMC: 4580433. DOI: 10.1371/journal.pone.0138652. View

Chi X, Britt E, Shows H, Hjelmaas A, Shetty S, Cushing E . ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase. Mol Metab. 2017; 6(10):1137-1149. PMC: 5641604. DOI: 10.1016/j.molmet.2017.06.014. View

Mehta N, Qamar A, Qu L, Qasim A, Mehta N, Reilly M . Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits. Arterioscler Thromb Vasc Biol. 2014; 34(5):1057-63. PMC: 4104779. DOI: 10.1161/ATVBAHA.113.302802. View

Aulchenko Y, Ripke S, Isaacs A, Van Duijn C . GenABEL: an R library for genome-wide association analysis. Bioinformatics. 2007; 23(10):1294-6. DOI: 10.1093/bioinformatics/btm108. View

Aung L, Yin R, Wu D, Wang W, Liu C, Pan S . Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia. J Cell Mol Med. 2014; 18(7):1417-28. PMC: 4124025. DOI: 10.1111/jcmm.12291. View

Rohloff J, Gelinas A, Jarvis T, Ochsner U, Schneider D, Gold L . Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents. Mol Ther Nucleic Acids. 2014; 3:e201. PMC: 4217074. DOI: 10.1038/mtna.2014.49. View

10.

Shan L, Yu X, Liu Z, Hu Y, Sturgis L, Miranda M . The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J Biol Chem. 2008; 284(3):1419-24. PMC: 3769808. DOI: 10.1074/jbc.M808477200. View

11.

Dijk W, Kersten S . Regulation of lipid metabolism by angiopoietin-like proteins. Curr Opin Lipidol. 2016; 27(3):249-56. DOI: 10.1097/MOL.0000000000000290. View

12.

Shimamura M, Matsuda M, Yasumo H, Okazaki M, Fujimoto K, Kono K . Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol. 2006; 27(2):366-72. DOI: 10.1161/01.ATV.0000252827.51626.89. View

13.

Carayol J, Chabert C, Di Cara A, Armenise C, Lefebvre G, Langin D . Protein quantitative trait locus study in obesity during weight-loss identifies a leptin regulator. Nat Commun. 2017; 8(1):2084. PMC: 5727191. DOI: 10.1038/s41467-017-02182-z. View

14.

Das S, Forer L, Schonherr S, Sidore C, Locke A, Kwong A . Next-generation genotype imputation service and methods. Nat Genet. 2016; 48(10):1284-1287. PMC: 5157836. DOI: 10.1038/ng.3656. View

15.

Romeo S, Yin W, Kozlitina J, Pennacchio L, Boerwinkle E, Hobbs H . Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest. 2008; 119(1):70-9. PMC: 2613476. DOI: 10.1172/JCI37118. View

16.

Zhang R . The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. Open Biol. 2016; 6(4):150272. PMC: 4852456. DOI: 10.1098/rsob.150272. View

17.

Shoji T, Hatsuda S, Tsuchikura S, Kimoto E, Kakiya R, Tahara H . Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia. Atherosclerosis. 2009; 207(2):579-84. DOI: 10.1016/j.atherosclerosis.2009.05.023. View

18.

Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T . Angptl3 regulates lipid metabolism in mice. Nat Genet. 2002; 30(2):151-7. DOI: 10.1038/ng814. View

19.

Larsen T, Dalskov S, van Baak M, Jebb S, Kafatos A, Pfeiffer A . The Diet, Obesity and Genes (Diogenes) Dietary Study in eight European countries - a comprehensive design for long-term intervention. Obes Rev. 2009; 11(1):76-91. DOI: 10.1111/j.1467-789X.2009.00603.x. View

20.

Delgado-Lista J, Perez-Jimenez F, Ruano J, Perez-Martinez P, Fuentes F, Criado-Garcia J . Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men. J Lipid Res. 2009; 51(1):63-73. PMC: 2789787. DOI: 10.1194/jlr.M800527-JLR200. View